Asahi Zenyteex Guiding Catheter
FDA Clearance Information
The Asahi Zenyteex Guiding Catheter was cleared by the FDA through the 510(k) pathway on February 26, 2010. Manufactured by Asahi Intecc, it is classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- Percutaneous catheter intended to access blood vessels and facilitate the delivery of interventional devices.
- Use is limited to the specific vessel-access, compatibility, and delivery indications in the current FDA-cleared labeling and instructions for use.
Clinical Applications
- Providing a vascular pathway for delivery of compatible interventional devices.
- Supporting catheter-based access during image-guided endovascular procedures.
- Navigating through the vasculature to a target treatment site when catheter support is required.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The available FDA summary does not specify the catheter's complete size range, working length, tip configuration, guidewire compatibility, or maximum injection pressure; users should consult the current manufacturer instructions for use.
- Compatibility with introducer sheaths, guidewires, contrast media, and other interventional devices must be confirmed before use.
- The procedure is typically performed through percutaneous vascular access under fluoroscopic or other appropriate imaging guidance, with local anesthesia and sedation as clinically indicated.
- Potential complications include vascular injury, bleeding or hematoma at the access site, thrombosis, embolization, infection, arrhythmia, contrast reaction, and loss of catheter integrity.
- MRI safety and conditional-use requirements are not established by the information provided here; check the current labeling before an MRI examination.
Procedures that use this device
Frequently Asked Questions
What are the clinical indications for Asahi Zenyteex Guiding Catheter?
The Asahi Zenyteex Guiding Catheter is indicated for use in venous stenting procedures, particularly in complex percutaneous coronary interventions.
What outcomes have been reported in clinical studies?
Studies have reported successful procedural outcomes in complex percutaneous coronary interventions, with improved navigation and support provided by the catheter.
What complications have been reported?
Safety data from evidence indicate potential radial trauma in transradial access, though overall adverse events are low.